Rockefeller Capital Management
ORGO icon

Rockefeller Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Rockefeller Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.4K Buy
6,487
+5,186
+399% +$18K ﹤0.01% 3818
2025
Q4 		$6.74K Buy
+1,301
New +$6.3K ﹤0.01% 3965
2023
Q1 		– Sell
-38
Closed – – 3297
2022
Q4 		$0 Hold
38
– – ﹤0.01% 4115
2022
Q3 		$0 Buy
+38
New +$172 ﹤0.01% 4246

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Rockefeller Capital Management's ORGO Position: Q1 2026 in Review

Rockefeller Capital Management increased its Organogenesis Holdings (ORGO) stake by 399% in Q1 2026, buying an estimated $18K and bringing the position to 6,487 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3818.

Rockefeller Capital Management first reported a position in ORGO in Q3 2022 and has held it in 4 quarters since. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Rockefeller Capital Management held 6,487 shares of Organogenesis Holdings worth $15.4K as of Q1 2026.
  • Rockefeller Capital Management bought 5,186 Organogenesis Holdings shares in Q1 2026, an estimated $18K.
  • Organogenesis Holdings made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3818 holding.
  • Rockefeller Capital Management first reported a position in Organogenesis Holdings in Q3 2022 and has held it in 4 quarters since.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.